Home

poškrábat Porucha Šalvěj cd38 m1 marker Stevenson papírnictví okraj

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts  responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma  | Journal for ImmunoTherapy of Cancer
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer

Aging-related inflammation driven by cellular senescence enhances NAD  consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv

Genes | Free Full-Text | Macrophage Polarization in Atherosclerosis
Genes | Free Full-Text | Macrophage Polarization in Atherosclerosis

Frontiers | CD38: A Significant Regulator of Macrophage Function
Frontiers | CD38: A Significant Regulator of Macrophage Function

Two Types of Macrophages: M1 and M2 Macrophages - Cusabio
Two Types of Macrophages: M1 and M2 Macrophages - Cusabio

Aging-related inflammation driven by cellular senescence enhances NAD  consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv

PTIP governs NAD+ metabolism by regulating CD38 expression to drive  macrophage inflammation - ScienceDirect
PTIP governs NAD+ metabolism by regulating CD38 expression to drive macrophage inflammation - ScienceDirect

Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab  in Multiple Myeloma
Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma

Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE

Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in  Inflammatory Conditions
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions

CD38 and other M1 markers in macrophages treated with SASP. (A)... |  Download Scientific Diagram
CD38 and other M1 markers in macrophages treated with SASP. (A)... | Download Scientific Diagram

Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE

Clinical significance of CD38 and CD101 expression in PD‑1+CD8+ T cells in  patients with epithelial ovarian cancer
Clinical significance of CD38 and CD101 expression in PD‑1+CD8+ T cells in patients with epithelial ovarian cancer

Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE

Two Types of Macrophages: M1 and M2 Macrophages - Cusabio
Two Types of Macrophages: M1 and M2 Macrophages - Cusabio

Novel Markers to Delineate Murine M1 and M2 Macrophages
Novel Markers to Delineate Murine M1 and M2 Macrophages

M1 Macrophage Flow Cytometry Panel: R&D Systems
M1 Macrophage Flow Cytometry Panel: R&D Systems

CD38 is methylated in prostate cancer and regulates extracellular NAD+ |  Cancer & Metabolism | Full Text
CD38 is methylated in prostate cancer and regulates extracellular NAD+ | Cancer & Metabolism | Full Text

Expression of CD38 and Egr2 protein in M0, M1 and M2 macrophages.
Expression of CD38 and Egr2 protein in M0, M1 and M2 macrophages.

CD38 Monoclonal Antibody (90), PerCP-eFluor™ 710 (46-0381-82)
CD38 Monoclonal Antibody (90), PerCP-eFluor™ 710 (46-0381-82)

Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE

Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in  Inflammatory Conditions
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions

Reprogramming of macrophages with macrophage cell membrane-derived  nanoghosts - Nanoscale Advances (RSC Publishing) DOI:10.1039/D0NA00572J
Reprogramming of macrophages with macrophage cell membrane-derived nanoghosts - Nanoscale Advances (RSC Publishing) DOI:10.1039/D0NA00572J

Reprogramming of macrophages with macrophage cell membrane-derived  nanoghosts - Nanoscale Advances (RSC Publishing) DOI:10.1039/D0NA00572J
Reprogramming of macrophages with macrophage cell membrane-derived nanoghosts - Nanoscale Advances (RSC Publishing) DOI:10.1039/D0NA00572J

CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews

Increased CD38 expression in human M(LPS + IFN-γ) monocyte-derived... |  Download Scientific Diagram
Increased CD38 expression in human M(LPS + IFN-γ) monocyte-derived... | Download Scientific Diagram

The NADase CD38 is induced by factors secreted from senescent cells  providing a potential link between senescence and age-related cellular NAD+  decline. - Abstract - Europe PMC
The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ decline. - Abstract - Europe PMC

Evolving roles of CD38 metabolism in solid tumour microenvironment |  British Journal of Cancer
Evolving roles of CD38 metabolism in solid tumour microenvironment | British Journal of Cancer

CD38 and Regulation of the Immune Response Cells in Cancer
CD38 and Regulation of the Immune Response Cells in Cancer